Global Chronic Kidney Disease (CKD) Market Research Report 2019

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Chronic Kidney Disease (CKD) Revenue
• 1.4 Market by Type
  • 1.4.1 Global Chronic Kidney Disease (CKD) Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 ACE Inhibitors
  • 1.4.3 Calcium Channel Blockers
  • 1.4.4 Beta Blockers
  • 1.4.5 Others
• 1.5 Market by Application
  • 1.5.1 Global Chronic Kidney Disease (CKD) Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospitals
  • 1.5.3 Specialty Clinics
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Chronic Kidney Disease (CKD) Market Perspective (2015-2026)
• 2.2 Global Chronic Kidney Disease (CKD) Growth Trends by Regions
  • 2.2.1 Chronic Kidney Disease (CKD) Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Chronic Kidney Disease (CKD) Historic Market Share by Regions (2015-2020)
  • 2.2.3 Chronic Kidney Disease (CKD) Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Chronic Kidney Disease (CKD) Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Chronic Kidney Disease (CKD) Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Chronic Kidney Disease (CKD) Players by Market Size
  • 3.1.1 Global Top Chronic Kidney Disease (CKD) Players by Revenue (2015-2020)
  • 3.1.2 Global Chronic Kidney Disease (CKD) Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Chronic Kidney Disease (CKD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Chronic Kidney Disease (CKD) Market Concentration Ratio
  • 3.2.1 Global Chronic Kidney Disease (CKD) Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Chronic Kidney Disease (CKD) Revenue in 2019
• 3.3 Chronic Kidney Disease (CKD) Key Players Head office and Area Served
• 3.4 Key Players Chronic Kidney Disease (CKD) Product Solution and Service
• 3.5 Date of Enter into Chronic Kidney Disease (CKD) Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Chronic Kidney Disease (CKD) Historic Market Size by Type (2015-2020)
• 4.2 Global Chronic Kidney Disease (CKD) Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Chronic Kidney Disease (CKD) Market Size by Application (2015-2020)
• 5.2 Global Chronic Kidney Disease (CKD) Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Chronic Kidney Disease (CKD) Market Size (2015-2020)
• 6.2 Chronic Kidney Disease (CKD) Key Players in North America (2019-2020)
• 6.3 North America Chronic Kidney Disease (CKD) Market Size by Type (2015-2020)
• 6.4 North America Chronic Kidney Disease (CKD) Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Chronic Kidney Disease (CKD) Market Size (2015-2020)
• 7.2 Chronic Kidney Disease (CKD) Key Players in Europe (2019-2020)
• 7.3 Europe Chronic Kidney Disease (CKD) Market Size by Type (2015-2020)
• 7.4 Europe Chronic Kidney Disease (CKD) Market Size by Application (2015-2020)

8 China

• 8.1 China Chronic Kidney Disease (CKD) Market Size (2015-2020)
• 8.2 Chronic Kidney Disease (CKD) Key Players in China (2019-2020)
• 8.3 China Chronic Kidney Disease (CKD) Market Size by Type (2015-2020)
• 8.4 China Chronic Kidney Disease (CKD) Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Chronic Kidney Disease (CKD) Market Size (2015-2020)
• 9.2 Chronic Kidney Disease (CKD) Key Players in Japan (2019-2020)
• 9.3 Japan Chronic Kidney Disease (CKD) Market Size by Type (2015-2020)
• 9.4 Japan Chronic Kidney Disease (CKD) Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Chronic Kidney Disease (CKD) Market Size (2015-2020)
• 10.2 Chronic Kidney Disease (CKD) Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Chronic Kidney Disease (CKD) Market Size by Type (2015-2020)
• 10.4 Southeast Asia Chronic Kidney Disease (CKD) Market Size by Application (2015-2020)

11 India

• 11.1 India Chronic Kidney Disease (CKD) Market Size (2015-2020)
• 11.2 Chronic Kidney Disease (CKD) Key Players in India (2019-2020)
• 11.3 India Chronic Kidney Disease (CKD) Market Size by Type (2015-2020)
• 11.4 India Chronic Kidney Disease (CKD) Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Chronic Kidney Disease (CKD) Market Size (2015-2020)
• 12.2 Chronic Kidney Disease (CKD) Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Chronic Kidney Disease (CKD) Market Size by Type (2015-2020)
• 12.4 Central & South America Chronic Kidney Disease (CKD) Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 AbbVie
  • 13.1.1 AbbVie Company Details
  • 13.1.2 AbbVie Business Overview
  • 13.1.3 AbbVie Chronic Kidney Disease (CKD) Introduction
  • 13.1.4 AbbVie Revenue in Chronic Kidney Disease (CKD) Business (2015-2020))
  • 13.1.5 AbbVie Recent Development
• 13.2 Allergan
  • 13.2.1 Allergan Company Details
  • 13.2.2 Allergan Business Overview
  • 13.2.3 Allergan Chronic Kidney Disease (CKD) Introduction
  • 13.2.4 Allergan Revenue in Chronic Kidney Disease (CKD) Business (2015-2020)
  • 13.2.5 Allergan Recent Development
• 13.3 Amgen
  • 13.3.1 Amgen Company Details
  • 13.3.2 Amgen Business Overview
  • 13.3.3 Amgen Chronic Kidney Disease (CKD) Introduction
  • 13.3.4 Amgen Revenue in Chronic Kidney Disease (CKD) Business (2015-2020)
  • 13.3.5 Amgen Recent Development
• 13.4 AstraZeneca
  • 13.4.1 AstraZeneca Company Details
  • 13.4.2 AstraZeneca Business Overview
  • 13.4.3 AstraZeneca Chronic Kidney Disease (CKD) Introduction
  • 13.4.4 AstraZeneca Revenue in Chronic Kidney Disease (CKD) Business (2015-2020)
  • 13.4.5 AstraZeneca Recent Development
• 13.5 Roche
  • 13.5.1 Roche Company Details
  • 13.5.2 Roche Business Overview
  • 13.5.3 Roche Chronic Kidney Disease (CKD) Introduction
  • 13.5.4 Roche Revenue in Chronic Kidney Disease (CKD) Business (2015-2020)
  • 13.5.5 Roche Recent Development
• 13.6 FibroGen
  • 13.6.1 FibroGen Company Details
  • 13.6.2 FibroGen Business Overview
  • 13.6.3 FibroGen Chronic Kidney Disease (CKD) Introduction
  • 13.6.4 FibroGen Revenue in Chronic Kidney Disease (CKD) Business (2015-2020)
  • 13.6.5 FibroGen Recent Development
• 13.7 GlaxoSmithKline
  • 13.7.1 GlaxoSmithKline Company Details
  • 13.7.2 GlaxoSmithKline Business Overview
  • 13.7.3 GlaxoSmithKline Chronic Kidney Disease (CKD) Introduction
  • 13.7.4 GlaxoSmithKline Revenue in Chronic Kidney Disease (CKD) Business (2015-2020)
  • 13.7.5 GlaxoSmithKline Recent Development
• 13.8 Johnson & Johnson
  • 13.8.1 Johnson & Johnson Company Details
  • 13.8.2 Johnson & Johnson Business Overview
  • 13.8.3 Johnson & Johnson Chronic Kidney Disease (CKD) Introduction
  • 13.8.4 Johnson & Johnson Revenue in Chronic Kidney Disease (CKD) Business (2015-2020)
  • 13.8.5 Johnson & Johnson Recent Development
• 13.9 Keryx
  • 13.9.1 Keryx Company Details
  • 13.9.2 Keryx Business Overview
  • 13.9.3 Keryx Chronic Kidney Disease (CKD) Introduction
  • 13.9.4 Keryx Revenue in Chronic Kidney Disease (CKD) Business (2015-2020)
  • 13.9.5 Keryx Recent Development
• 13.10 Kissei
  • 13.10.1 Kissei Company Details
  • 13.10.2 Kissei Business Overview
  • 13.10.3 Kissei Chronic Kidney Disease (CKD) Introduction
  • 13.10.4 Kissei Revenue in Chronic Kidney Disease (CKD) Business (2015-2020)
  • 13.10.5 Kissei Recent Development
• 13.11 Pfizer
  • 10.11.1 Pfizer Company Details
  • 10.11.2 Pfizer Business Overview
  • 10.11.3 Pfizer Chronic Kidney Disease (CKD) Introduction
  • 10.11.4 Pfizer Revenue in Chronic Kidney Disease (CKD) Business (2015-2020)
  • 10.11.5 Pfizer Recent Development
• 13.12 Sanofi
  • 10.12.1 Sanofi Company Details
  • 10.12.2 Sanofi Business Overview
  • 10.12.3 Sanofi Chronic Kidney Disease (CKD) Introduction
  • 10.12.4 Sanofi Revenue in Chronic Kidney Disease (CKD) Business (2015-2020)
  • 10.12.5 Sanofi Recent Development
• 13.13 Teva
  • 10.13.1 Teva Company Details
  • 10.13.2 Teva Business Overview
  • 10.13.3 Teva Chronic Kidney Disease (CKD) Introduction
  • 10.13.4 Teva Revenue in Chronic Kidney Disease (CKD) Business (2015-2020)
  • 10.13.5 Teva Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer